Robert A. Copeland, EVP and CSO at Epizyme, Inc. (EPZM), sold 20,000 shares at $28.26 ($568K) on 2014-06-23, disclosed to the SEC on 2014-06-25.
Scheduled sale ($568k) by EVP and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.26 | 14,816 | $419K | 73.7% |
| 2 | $28.88 | 5,184 | $150K | 26.3% |
| Total | $28.42 avg | 20,000 | $568K | 100% |
| Filing → |
| EPZM | SELL | 2017-04-05 | $41K | — | Filing → |
| EPZM | SELL | 2016-08-03 | $83K | — | Filing → |
| EPZM | SELL | 2016-07-07 | $80K | — | Filing → |